title: Multiple lipoma with hyperlipidemia in a multiple myeloma patient treated with bortezomib/dexamethazone.
authors.forename: Moritaka
authors.initials: M
authors.lastname: Gotoh
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Kitahara
authors.forename: Juri
authors.initials: J
authors.lastname: Sakuta
authors.forename: Daigo
authors.initials: D
authors.lastname: Akahane
authors.forename: Kazuma
authors.initials: K
authors.lastname: Ohyashiki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage / Q000009:adverse effects; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D008067:Lipoma / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D009378:Neoplasms, Multiple Primary / Q000150:complications / Q000175:diagnosis; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone